文献速递肝病消化道肿瘤与早癌

mTORC1磷酸化雄激素受体促进肝脏脂肪变性与肿瘤发生

Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis.
PubMed 文献 · Hepatology · 2021-12-07

该研究探讨雄激素受体(AR)磷酸化及其与mTORC1在肝细胞癌(HCC)发生中的作用。体外实验发现mTORC1响应营养和促有丝分裂刺激,与肝脏AR互作并磷酸化其S96位点;S96磷酸化增强AR稳定性、核定位和转录活性,促进肝细胞新生脂肪生成和增殖,独立及协同雄激素诱导小鼠肝脏脂肪变性和肝癌发生。人肝脂肪变性和HCC组织中AR S96磷酸化水平高,与总生存和无病生存相关,并被证明是HCC患者的独立生存预测因子。

要点

  • mTORC1磷酸化AR S96增强其稳定性、核定位和转录活性。
  • AR S96磷酸化促进肝细胞脂肪生成和增殖,诱导小鼠肝脂肪变和肝癌。
  • 高AR S96磷酸化与HCC患者生存相关,为独立生存预测因子。

核心结论

  • mTORC1磷酸化AR S96独立及协同雄激素驱动肝脏脂肪变性和HCC发生发展,解释HCC男性偏倚并提供预防治疗靶点和生存预测标志。

研究设计与样本

  • 研究采用体外HCC细胞实验和小鼠体内实验,并分析人肝脂肪变性和HCC组织。

主要发现

  • 体外实验观察到mTORC1响应营养和促有丝分裂刺激与肝脏AR互作并磷酸化S96。
  • S96磷酸化促进AR稳定性、核定位和转录活性,增强肝细胞新生脂肪生成和增殖。
  • S96磷酸化独立及协同雄激素诱导小鼠肝脏脂肪变性和肝癌发生。
  • 人肝脂肪变性和HCC组织中AR S96磷酸化水平高,与总生存和无病生存相关。
  • AR S96磷酸化被证明是HCC患者的独立生存预测因子。

临床怎么用

  • AR S96磷酸化可作为HCC预防和治疗的潜在靶分子。
  • AR S96磷酸化水平可能作为HCC患者的生存预测指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Androgen receptor (AR) has been reported to play an important role in the development and progression of man's prostate cancer. Hepatocellular carcinoma (HCC) is also male-dominant, but the role of AR in HCC remains poorly understood. Mechanistic target of rapamycin complex 1 (mTORC1) also has been reported to be highly activated in HCC. In this study, we aimed to explore the role of AR phosphorylation and its relationship with mTORC1 in hepatocarcinogenesis. APPROACH AND RESULTS: In vitro experiment, we observed that mTORC1 interacts with hepatic AR and phosphorylates it at S96 in response to nutrient and mitogenic stimuli in HCC cells. S96 phosphorylation promotes the stability, nuclear localization, and transcriptional activity of AR, which enhances de novo lipogenesis and proliferation in hepatocytes and induces liver steatosis and hepatocarcinogenesis in mice independently and cooperatively with androgen. Furthermore, high ARS96 phosphorylation is observed in human liver steatotic and HCC tissues and is associated with overall survival and disease-free survival, which has been proven as an independent survival predictor for patients with HCC. CONCLUSIONS: AR S96 phosphorylation by mTORC1 drives liver steatosis and HCC development and progression independently and cooperatively with androgen, which not only explains why HCC is man-biased but also provides a target molecule for prevention and treatment of HCC and a potential survival predictor in patients with HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Ren QN, Zhang H, Sun CY, et al. Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis. Hepatology. 2021. PMID: 34435708. doi:10.1002/hep.32120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。